Resmed Inc stock is traded at $235.63, with a volume of 1,348,606. It is down -0.53% in the last 24 hours and down -4.02% over the past month. ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
Previous Close:
$236.88
Open:
$237.18
24h Volume:
1,348,606
Relative Volume:
1.17
Market Cap:
$33.14B
Revenue:
$5.54B
Net Income/Loss:
$1.52B
P/E Ratio:
22.71
EPS:
$10.37
Net Cash Flow:
$1.74B
1W Performance:
-1.63%
1M Performance:
-4.02%
6M Performance:
+12.28%
1Y Performance:
-3.40%
1-Day Range:
$234.70$242.43
1-Week Range:
$233.42$246.14
52-Week Range:
$180.27$277.67
Resmed Inc Stock (RMD) Company Profile
Name
Resmed IncSector
HealthcareIndustry
Medical Instruments & SuppliesPhone
(858) 746-2400Address
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS